Le Centre national hospitalier et universitaire Hubert Koutoukou Maga, créé le 30 octobre 1962 sous le mandat du président Hubert Maga, est le principal centre de santé implanté à Cotonou, la capitale économique du Bénin.

During the past decade, Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Institute of Tropical Medicine, Belgium" with 2 trials as a collaborator, "Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou, Benin" with 1 trials as a collaborator, "Centres de Diagnostic et de Traitement de la tuberculose, National Tuberculosis Programme, Benin" with 1 trials as a collaborator and "Cheikh Anta Diop University, Senegal" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou" are "Latent Tuberculosis Infection" (2 trials), "Tuberculosis" (1 trials) and "Tuberculosis, Multidrug-Resistant" (1 trials). Many other conditions were trialed in "Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou" in a lesser frequency.

Most popular intervention types in "Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou" are "Drug" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Isoniazid" (2 trials), "Rifampin" (2 trials), "Deeplex test, MolBio TrueNat for 2nd line, GeneXpert 2nd line" (1 trials), "Fluorescein DiAcetate (FDA) Microscopy,GeneXpert Ct value, pre-rRNA synthesis" (1 trials) and "No intervention (observational study)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".